Boston Scientific is expanding out of America and taking its single-use duodenoscope to Europe after the company received a CE mark for the device, Mass Device reports.
GI & Endoscopy
Grand Junction (Colo.) Gastroenterology opened a clinic for patients with liver disease, The Business Times reports.
Ironwood Pharmaceuticals and Allergan reached a settlement with Teva over Teva's abbreviated new drug application for a generic version of Linzess, a drug for irritable bowel syndrome with constipation.
Five must-read articles for GI leaders this week:
American Gastroenterological Association-affiliated researchers published a new clinical guideline on ulcerative colitis with 15 recommendations for treating the disease.
Advertisement
Here are five updates from gastroenterology companies and practices from the past week:
More children are developing inflammatory bowel disease, according to Medscape Medical News.
The U.S. gastroenterology-facing ASC market will hit $10.8 billion by 2026, according to a Grand View Research market report.
Fujifilm is creating a Systems Integration business to create a single-vendor offering that incorporates data and imaging into the operating room.
The Colorado Cancer Coalition and the American Cancer Society's Cancer Action Network are working to advance a bill to lower the colonoscopy screening age from 50 to 45 in the state, The Gazette reports.